JHS Svendgaard Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2025 ,inter alia, to consider and approve Un-Audited Financial ....
JHS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
JHS Svendgaard Laboratories has informed the stock exchanges that its Board of Directors will meet on Tuesday, 12 August 2025. The main agenda is to consider and approve the Unaudited Standalone and Consolidated Financial Results for the quarter ended 30 June 2025, along with the Limited Review Reports. Additionally, the Board will consider approving a new Employee Stock Option Scheme named 'JHS Svendgaard Laboratories Employee Stock Option Scheme – 2025' and the appointment of a Merchant Banker to implement this ESOP. The trading window for insiders has been closed since 1 July 2025 and will reopen 48 hours after the financial results are announced.
No direct impact on shareholders yet — this is a routine advance notice ahead of the Q1 FY26 earnings announcement on 12 August 2025. Investors should watch the actual results and any dilution impact from the proposed ESOP 2025 scheme.